INSIGHTS ON CLINICAL TRIAL DESIGN
-
The Role Of Oncology Biomarkers In Personalizing Hematology Treatment Plans
Oncology biomarkers guide personalized treatment and help track disease changes. Learn more about how advancements like liquid biopsies improve precision care.
-
Obesity Clinical Research: Patient Recruitment Challenges
Obesity trials face enrollment hurdles. Learn how data-driven insights, patient-first strategies, and decentralized models can break barriers, ease burden, and accelerate timelines.
-
Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells Us
Benchmarking immune challenge models clarifies early pharmacodynamic signals, helping teams distinguish true target engagement from variability, prioritize endpoints, and make confident decisions.
-
Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM)
The benefits are clear: CRM accelerates dose finding, reduces patient exposure to unsafe doses, and improves trial efficiency.
-
How Pharmaceutical Companies Can Effectively Engage With PAOs2/11/2025
Experts explain the role of Patient Advocacy Organizations (PAOs), tips for pharmaceutical companies and PAOs to forge strong relationships, and techniques to integrate patient perspectives.
-
Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays9/25/2025
Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.
-
Sustaining Participation In A 20-Year Alzheimer's Family Study8/14/2026
Learn how home-based visits can reduce burden, improve retention, and support long-term follow-up in complex clinical studies requiring years of continuous participation.
-
Flexible Supply Strategies For Complex Clinical Trials3/25/2026
Explore how demand-led, decentralized clinical supply models are reshaping complex trials by reducing waste, accelerating timelines, and advancing patient-centric access to investigational therapies.
-
Guiding GLP-1 Participants Through The Challenge Of Retention12/4/2025
Learn how remote lifestyle coaching can combat high dropout rates in metabolic research by offering the support participants need to maintain adherence and ensure data integrity.
CLINICAL TRIAL DESIGN SOLUTIONS
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
-
Explore this suite of multichannel, patient-centered solutions that are powering rapid clinical trial education, engagement, and enrollment.
-
Discover how a collaborative approach to medical writing ensures the highest standards of excellence and precision in every document produced.
-
Altasciences recruits from a large ethnic population in Southern California and have a dedicated Asian recruitment and outreach department to liaise with our participants.
-
From reminders to resource coordination, visit scheduling shouldn't slow trials down. Discover how automation can reduce deviations and support participants.